Cost-effectiveness Analysis of Reference Infliximab (Remicade) Compared to its Biosimilar (Remsima) in Iraqi Patients with Rheumatoid Arthritis (Conference Paper )#

The study objective was to conduct Pharmacoeconomics study (cost-effective analysis) between infliximab reference (Remicade) and its biosimilar (Remsima) in patients with rheumatoid arthritis (RA) in Iraqi hospitals. This is a retrospective multicenter pharmacoeconomic analysis conducted at two larg...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Hasan Raid Fadhil (Auteur), Ali Azeez Al-Jumaili (Auteur), Nizar Abdulateef Al-Ani (Auteur)
Formaat: Boek
Gepubliceerd in: College of Pharmacy University of Baghdad, 2023-02-01T00:00:00Z.
Onderwerpen:
Online toegang:Connect to this object online.
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

Connect to this object online.

3rd Floor Main Library

Exemplaargegevens van 3rd Floor Main Library
Plaatsingsnummer: A1234.567
Kopie 1 Beschikbaar